MYC and colorectal carcinoma: Moreover, ARI down-modulates both CD133, a well-known CSC marker whose association with CXCR4 defines a subset of highly metastatic CSCs [34], and c-Myc, one of the most critical transcription factor implicated in CRC transformation [35].